Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid
- PMID: 6607916
- DOI: 10.1093/jac/13.1.23
Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid
Abstract
Thirty-five beta-lactam-resistant isolates of the Bacteroides fragilis group were examined for the susceptibility to eight cephalosporins, alone, and in combination with a subinhibitory concentration of the beta-lactamase inhibitor, clavulanic acid. The majority of strains tested became fully susceptible to cephaloridine, cefotaxime and ceftriaxone in the presence of clavulinic acid whereas the effect of the inhibitor on the susceptibility to compounds such as cefsulodin and ceftazidime and to a lesser extent cefoperazone varied according to species. Bact. fragilis strains almost invariably showed substantial reductions in MICs whereas those of other species, especially Bact. thetaiotaomicron, were influenced to a lesser extent. Susceptibility to cefoxitin was unaffected by the inhibitor but a few strains with high level resistance to latamoxef (moxalactam) became susceptible in the presence of clavulanic acid. All strains were found to produce beta-lactamase as determined by the nitrocefin test and these were characterized by isoelectric focusing.
Similar articles
-
A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.Microbios. 1991;67(272-273):195-202. Microbios. 1991. PMID: 1779879
-
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.Antimicrob Agents Chemother. 1984 May;25(5):662-5. doi: 10.1128/AAC.25.5.662. Antimicrob Agents Chemother. 1984. PMID: 6732233 Free PMC article.
-
Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.Antimicrob Agents Chemother. 1985 Dec;28(6):773-7. doi: 10.1128/AAC.28.6.773. Antimicrob Agents Chemother. 1985. PMID: 3878690 Free PMC article.
-
Newer beta-lactam agents and the Bacteroides fragilis group.Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Pharmacotherapy. 1991. PMID: 2041832 Review.
-
Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.Clin Infect Dis. 1993 Jun;16 Suppl 4:S371-6. doi: 10.1093/clinids/16.supplement_4.s371. Clin Infect Dis. 1993. PMID: 8324150 Review.
Cited by
-
In vitro antibacterial effects of cephalosporins.Drugs. 1987;34 Suppl 2:44-63. doi: 10.2165/00003495-198700342-00006. Drugs. 1987. PMID: 3319505 Review.
-
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001. Drugs. 1984. PMID: 6329638 Review.
-
beta-Lactamases in laboratory and clinical resistance.Clin Microbiol Rev. 1995 Oct;8(4):557-84. doi: 10.1128/CMR.8.4.557. Clin Microbiol Rev. 1995. PMID: 8665470 Free PMC article. Review.
-
Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.Antimicrob Agents Chemother. 1987 Feb;31(2):321-2. doi: 10.1128/AAC.31.2.321. Antimicrob Agents Chemother. 1987. PMID: 3032097 Free PMC article.
-
In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):177-81. doi: 10.1007/BF01982195. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8013494
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources